Clinical Trial

Evaluation of the Efficacy of Therapeutic Infiltrations of the Pudendal Nerve, Performed Under Neurostimulation on Pain, 1 Month After an Infiltration of Local Anaesthetic, in the Treatment of Pudendal Neuralgia.

Study acronym: EPHI-DACI
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Pudendal neuralgia (PN) is a chronic nerve compression syndrome causing neuropathic pain. Treatment includes medication, infiltration and decompressive surgery. Medicinal treatment involves the use of drugs that have proved effective in other areas, such as shingles or diabetes. There is no consensus on the molecules to be used for pudendal nerve infiltration (PNTI), and less than half of patients experience short-term relief. The only risk factor for failure is the duration of pain. Our study proposes to compare the usual treatment with a placebo, as no type of infiltration has been compared with a placebo.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-10; most recent amendment 2025-05-16.
Trial Details
NCT Number NCT06872437
Lead Sponsor Groupe Hospitalier Diaconesses Croix Saint-Simon
Conditions Pudendal Neuralgia
Enrollment 60 participants
Start Date 2023-12-08
Primary Completion 2029-03-08 (estimated)
Study Completion 2029-03-08 (estimated)
Updated on ClinicalTrials.gov 2025-05-18